Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Iovance Biotherapeutics Inc
(NQ:
IOVA
)
7.960
-0.350 (-4.21%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stocks That Hit 52-Week Lows On Wednesday
May 19, 2021
On Wednesday morning, 19 companies hit new 52-week lows. Significant Points: Canadian Pacific Railway (NYSE:CP) was the largest company by market cap to set a new 52-week...
Via
Benzinga
Iovance Stock Faces A 'Not Trivial' Problem That Will Slam 2022 Sales
May 19, 2021
Iovance Biotherapeutics announced another delay for its experimental cancer drug late Tuesday and IOVA stock plummeted on Wednesday.
Via
Investor's Business Daily
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 19, 2021
Gainers Advaxis (NASDAQ:ADXS) shares increased by 27.34% to $0.62 during Wednesday's pre-market session. The company's market cap stands at $85.2 million. Lixte...
Via
Benzinga
The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics
May 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
Iovance's Lifileucel US Application Submission Pushed To 2022
May 19, 2021
Iovance Biotherapeutics Inc (NASDAQ: IOVA) has received regulatory feedback from the FDA on its potency assays for lifileucel. Following FDA feedback, Iovance will...
Via
Benzinga
Exposures
Product Safety
ARKK Stocks Breakdowns and Bounces
May 07, 2021
After struggling for most of the past couple of months, momentum and Tech stocks are broadly outperforming today.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For April 16, 2021
April 16, 2021
Upgrades According to Argus Research, the prior rating for United Airlines Holdings Inc (NASDAQ:UAL) was changed from Hold to Buy. In the fourth quarter, United Airlines...
Via
Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
May 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
28 Stocks Moving in Friday's Pre-Market Session
April 16, 2021
Gainers Mer Telemanagement Solutions Ltd. (NASDAQ: MTSL) rose 63.1% to $4.68 in pre-market trading after the company announced it signed a definitive merger agreement with...
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.